News
Mallinckrodt and Endo to combine in $6.7 billion merger
Mallinckrodt and Endo have entered into a definitive agreement to combine in a $6.7 billion deal, after the companies emerged from bankruptcy in connection...
Merck opens $1bn facility to increase vaccine production capacity
Merck (known as MSD outside of the United States and Canada) has opened a new, $1 billion, 225,000 sq ft facility dedicated to vaccine...
Ono enters license agreement with Ionis for polycythemia vera treatment sapablursen
Ono Pharmaceutical has entered into a license agreement with Ionis Pharmaceuticals for sapablursen, an investigational RNA-targeted medicine for the treatment of polycythemia vera (PV).
Sapablursen...
